Effects of GLP-1 Agonists on CArdiac Steatosis Evaluated by Magnetic Resonance Imaging
NCT03498001
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Type II Diabetes
Interventions
DRUG:
GLP-1 agonists
PROCEDURE:
Cardiac MRI
OTHER:
Follow up by phone
Sponsor
Centre Hospitalier Universitaire Dijon